Narlumosbart (JMT103) is a monoclonal antibody of the IgG4?? subtype designed to specifically target the receptor activator of nuclear factor-??B ligand (RANKL). This antibody is engineered to interact with RANKL, a critical mediator in the regulation of bone metabolism, immune interactions, and the development of lymphoid tissues. Narlumosbart is utilized primarily in research focused on bone diseases, immune system disorders, and cancer metastasis to bone.
Narlumosbart (JMT103) is a monoclonal antibody of the IgG4?? subtype designed to specifically target the receptor activator of nuclear factor-??B ligand (RANKL). This antibody is engineered to interact with RANKL, a critical mediator in the regulation of bone metabolism, immune interactions, and the development of lymphoid tissues. Narlumosbart is utilized primarily in research focused on bone diseases, immune system disorders, and cancer metastasis to bone.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
